Dubai – The 29th edition of the Dubai International Pharmacy Technologies Conference and Exhibition, Duphat 2024, concluded with the sealing of trade deals worth AED8.5 billion ($2.31 billion). Dr Ali Al Sayed Hussain, Chairman of Duphat, emphasized the event’s role in economically and academically supporting the pharmaceutical industry by fostering partnerships among stakeholders and professionals.
Duphat 2024 played a pivotal role in fortifying the UAE economy, contributing significantly to the retail and tourism sectors. Dr AbdulSalam AlMadani, Executive Chairman of Duphat, highlighted the event’s alignment with the UAE’s vision of becoming a premier destination for commerce and tourism. The achieved deals underscore the industry’s ambition and place Dubai in the Global City Strength Index.
The event facilitated crucial deals and meetings, connecting participants with customers, suppliers, and manufacturers in the pharmaceutical and technology realms. The positive outcomes have reinforced participants’ commitment to ensuring their presence in the forthcoming years.
The closing ceremony acknowledged poster presenters for their research contributions and recognized stand designs that creatively highlighted new technologies in the pharmaceutical industry.
Duphat, organized annually by Index Conferences and Exhibitions, is supported by prominent entities like Dubai Health Authority, American Society of Health-System Pharmacists, International Society for Pharmacoepidemiology, European Federation for Pharmaceutical Sciences, European Society of Clinical Pharmacy, Society of Hospital Pharmacists of Australia, and the European Society of Oncology Pharmacy. The event continues to be a key platform for advancements in pharmacy technologies, fostering innovation and collaboration within the industry.
